{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:33:02Z","timestamp":1789752782433,"version":"4.0.1"},"reference-count":50,"publisher":"Informa UK Limited","issue":"8","funder":[{"name":"Nicolaus Copernicus University"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Cell Cycle"],"published-print":{"date-parts":[[2023,4,18]]},"DOI":"10.1080\/15384101.2022.2162668","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T14:59:05Z","timestamp":1672239545000},"page":"859-869","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["The role of cyclin Y in normal and pathological cells"],"prefix":"10.1080","volume":"22","author":[{"given":"Aleksandra","family":"Opacka","sequence":"first","affiliation":[{"name":"Department of Histology and Embryology, Nicolaus Copernicus University in Toru\u0144, Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"\u017bury\u0144","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Nicolaus Copernicus University in Toru\u0144, Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9172-2698","authenticated-orcid":false,"given":"Adrian","family":"Krajewski","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Nicolaus Copernicus University in Toru\u0144, Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Miko\u0142ajczyk","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Nicolaus Copernicus University in Toru\u0144, Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"issue":"15","key":"e_1_3_3_2_1","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1242\/dev.091744","article-title":"Cdks, cyclins and CKIs: roles beyond cell cycle regulation","volume":"140","author":"Lim S","year":"2013","unstructured":"Lim S, Kaldis P. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development. 2013;140(15):3079\u20133093.","journal-title":"Development"},{"issue":"7","key":"e_1_3_3_3_1","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbamcr.2010.04.004","article-title":"A cancer-derived mutation in the PSTAIRE helix of cyclin-dependent kinase 2 alters the stability of cyclin binding","volume":"1803","author":"Child ES","year":"2010","unstructured":"Child ES, Hendrychov\u00e1 T, McCague K, et al. A cancer-derived mutation in the PSTAIRE helix of cyclin-dependent kinase 2 alters the stability of cyclin binding. Biochim Biophys Acta. 2010;1803(7):858\u2013864.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"e_1_3_3_4_1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00018-002-8410-1","article-title":"Regulation of cyclin-Cdk activity in mammalian cells","volume":"59","author":"Obaya AJ","year":"2002","unstructured":"Obaya AJ, Sedivy JM. Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol Life Sci. 2002;59(1):126\u2013142.","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"e_1_3_3_5_1","doi-asserted-by":"crossref","first-page":"180112","DOI":"10.1098\/rsob.180112","article-title":"Structural insights into the functional diversity of the CDK\u2013cyclin family","volume":"8","author":"Wood DJ","year":"2018","unstructured":"Wood DJ, Endicott JA. Structural insights into the functional diversity of the CDK\u2013cyclin family. Open Biol. 2018;8(9):180112.","journal-title":"Open Biol"},{"issue":"2","key":"e_1_3_3_6_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto T","year":"2017","unstructured":"Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 2017;17(2):93\u2013115.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"e_1_3_3_7_1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1534\/genetics.110.114017","article-title":"Cyclin Y is a novel conserved cyclin essential for development in drosophila","volume":"184","author":"Liu D","year":"2010","unstructured":"Liu D, Finley RL. Cyclin Y is a novel conserved cyclin essential for development in drosophila. Genet. 2010;184(4):1025\u20131035.","journal-title":"Genet"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-16-5812-9_2"},{"issue":"1","key":"e_1_3_3_9_1","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1038\/srep12624","article-title":"Cyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP","volume":"5","author":"Cho E","year":"2015","unstructured":"Cho E, Kim D-H, Hur Y-N, et al. Cyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP. Sci Rep. 2015;5(1):12624.","journal-title":"Sci Rep"},{"issue":"13","key":"e_1_3_3_10_1","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.febslet.2009.06.010","article-title":"Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1","volume":"583","author":"Jiang M","year":"2009","unstructured":"Jiang M, Gao Y, Yang T, et al. Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1. FEBS Lett. 2009;583(13):2171\u20132178.","journal-title":"FEBS Lett"},{"issue":"4","key":"e_1_3_3_11_1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/MCB.06261-11","article-title":"Cyclin-Dependent Kinase 16\/PCTAIRE kinase 1 is activated by Cyclin Y and is essential for spermatogenesis","volume":"32","author":"Mikolcevic P","year":"2012","unstructured":"Mikolcevic P, Sigl R, Rauch V, et al. Cyclin-Dependent Kinase 16\/PCTAIRE kinase 1 is activated by Cyclin Y and is essential for spermatogenesis. Mol Cell Biol. 2012;32(4):868\u2013879.","journal-title":"Mol Cell Biol"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.12659\/MSM.906075","article-title":"Cyclin Y modulates the proliferation, invasion, and metastasis of hepatocellular carcinoma cells","volume":"24","author":"Shi K","year":"2018","unstructured":"Shi K, Ru Q, Zhang C, et al. Cyclin Y modulates the proliferation, invasion, and metastasis of hepatocellular carcinoma cells. Med Sci Monit. 2018;24:1642\u20131653.","journal-title":"Med Sci Monit"},{"issue":"2","key":"e_1_3_3_13_1","doi-asserted-by":"crossref","first-page":"e0172547","DOI":"10.1371\/journal.pone.0172547","article-title":"Cyclin Y-mediated transcript profiling reveals several important functional pathways regulated by Cyclin Y in hippocampal neurons","volume":"12","author":"Joe I-S","year":"2017","unstructured":"Joe I-S, Kim J-H, Kim H, et al. Cyclin Y-mediated transcript profiling reveals several important functional pathways regulated by Cyclin Y in hippocampal neurons. PLoS ONE. 2017;12(2):e0172547.","journal-title":"PLoS ONE"},{"issue":"8","key":"e_1_3_3_14_1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/genes11080939","article-title":"Wnt\/\u03b2-catenin signaling in tissue self-organization","volume":"11","author":"Pond KW","year":"2020","unstructured":"Pond KW, Doubrovinski K, Thorne CA. Wnt\/\u03b2-catenin signaling in tissue self-organization. Genes. 2020;11(8):939.","journal-title":"Genes"},{"issue":"2","key":"e_1_3_3_15_1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s12276-020-0380-6","article-title":"Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond \u03b2-catenin and the destruction complex","volume":"52","author":"Jung Y-S","year":"2020","unstructured":"Jung Y-S, Park J-I. Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond \u03b2-catenin and the destruction complex. Exp Mol Med. 2020;52(2):183\u2013191.","journal-title":"Exp Mol Med"},{"issue":"3","key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"e1008021","DOI":"10.1371\/journal.pgen.1008021","article-title":"Correction: cCNYL1, but not CCNY, cooperates with CDK16 to regulate spermatogenesis in mouse","volume":"15","author":"Zi Z","year":"2019","unstructured":"Zi Z, Zhang Z, Li Q, et al. Correction: cCNYL1, but not CCNY, cooperates with CDK16 to regulate spermatogenesis in mouse. PLoS Genet. 2019;15(3):e1008021.","journal-title":"PLoS Genet"},{"issue":"7","key":"e_1_3_3_17_1","doi-asserted-by":"crossref","first-page":"e0132721","DOI":"10.1371\/journal.pone.0132721","article-title":"Cyclin Y is involved in the regulation of adipogenesis and lipid production","volume":"10","author":"An W","year":"2015","unstructured":"An W, Zhang Z, Zeng L, et al. Cyclin Y is involved in the regulation of adipogenesis and lipid production. PLoS ONE. 2015;10(7):e0132721.","journal-title":"PLoS ONE"},{"issue":"1","key":"e_1_3_3_18_1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbrc.2014.05.002","article-title":"PFTK1 interacts with cyclin Y to activate non-canonical Wnt signaling in hepatocellular carcinoma","volume":"449","author":"Sun T","year":"2014","unstructured":"Sun T, Co NN, Wong N. PFTK1 interacts with cyclin Y to activate non-canonical Wnt signaling in hepatocellular carcinoma. Biochem Biophys Res Commun. 2014;449(1):163\u2013168.","journal-title":"Biochem Biophys Res Commun"},{"issue":"51","key":"e_1_3_3_19_1","doi-asserted-by":"crossref","first-page":"26427","DOI":"10.1074\/jbc.M116.744607","article-title":"Activation\/proliferation-associated Protein 2 (Caprin-2) Positively Regulates CDK14\/Cyclin Y-mediated Lipoprotein Receptor-related Protein 5 and 6 (LRP5\/6) Constitutive Phosphorylation","volume":"291","author":"Wang X","year":"2016","unstructured":"Wang X, Jia Y, Fei C, et al. Activation\/proliferation-associated Protein 2 (Caprin-2) Positively Regulates CDK14\/Cyclin Y-mediated Lipoprotein Receptor-related Protein 5 and 6 (LRP5\/6) Constitutive Phosphorylation. J Biol Chem. 2016;291(51):26427\u201326434.","journal-title":"J Biol Chem"},{"issue":"2","key":"e_1_3_3_20_1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/15548627.2017.1378838","article-title":"Autophagy pathway: cellular and molecular mechanisms","volume":"14","author":"Yu L","year":"2018","unstructured":"Yu L, Chen Y, Tooze SA. Autophagy pathway: cellular and molecular mechanisms. Autophagy. 2018;14(2):207\u2013215.","journal-title":"Autophagy"},{"issue":"1","key":"e_1_3_3_21_1","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41467-020-14812-0","article-title":"AMPK-dependent activation of the Cyclin Y\/CDK16 complex controls autophagy","volume":"11","author":"Dohmen M","year":"2020","unstructured":"Dohmen M, Krieg S, Agalaridis G, et al. AMPK-dependent activation of the Cyclin Y\/CDK16 complex controls autophagy. Nat Commun. 2020;11(1):1032.","journal-title":"Nat Commun"},{"issue":"9","key":"e_1_3_3_22_1","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1080\/15548627.2020.1795423","article-title":"The CCNY (cyclin Y)-CDK16 kinase complex: a new regulator of autophagy downstream of AMPK","volume":"16","author":"Vervoorts J","year":"2020","unstructured":"Vervoorts J, Neumann D, L\u00fcscher B. The CCNY (cyclin Y)-CDK16 kinase complex: a new regulator of autophagy downstream of AMPK. Autophagy. 2020;16(9):1724\u20131726.","journal-title":"Autophagy"},{"issue":"6","key":"e_1_3_3_23_1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/15548627.2020.1756665","article-title":"New tricks of an old autophagy regulator: aMPK-dependent regulation of autophagy through CCNY (cyclin Y)-CDK16","volume":"16","author":"Gatica D","year":"2020","unstructured":"Gatica D, Klionsky DJ. New tricks of an old autophagy regulator: aMPK-dependent regulation of autophagy through CCNY (cyclin Y)-CDK16. Autophagy. 2020;16(6):973\u2013974.","journal-title":"Autophagy"},{"key":"e_1_3_3_24_1","doi-asserted-by":"crossref","first-page":"101915","DOI":"10.1016\/j.pneurobio.2020.101915","article-title":"Cyclin Y, a novel actin-binding protein, regulates spine plasticity through the cofilin-actin pathway","volume":"198","author":"Hwang H","year":"2021","unstructured":"Hwang H, Hur Y-N, Sohn H, et al. Cyclin Y, a novel actin-binding protein, regulates spine plasticity through the cofilin-actin pathway. Prog Neurobiol. 2021;198:101915.","journal-title":"Prog Neurobiol"},{"issue":"5","key":"e_1_3_3_25_1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.cell.2010.04.011","article-title":"Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components","volume":"141","author":"Ou C-Y","year":"2010","unstructured":"Ou C-Y, Poon VY, Maeder CI, et al. Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components. Cell. 2010;141(5):846\u2013858.","journal-title":"Cell"},{"key":"e_1_3_3_26_1","doi-asserted-by":"crossref","first-page":"105100","DOI":"10.1016\/j.phrs.2020.105100","article-title":"Ccny knockout mice display an enhanced susceptibility to kainic acid-induced epilepsy","volume":"160","author":"Hwang H","year":"2020","unstructured":"Hwang H, Seo J, Choi Y, et al. Ccny knockout mice display an enhanced susceptibility to kainic acid-induced epilepsy. Pharmacol Res. 2020;160:105100.","journal-title":"Pharmacol Res"},{"issue":"25","key":"e_1_3_3_27_1","doi-asserted-by":"crossref","first-page":"24004","DOI":"10.1074\/jbc.M501080200","article-title":"Wnt signaling inhibits adipogenesis through \u03b2-catenin-dependent and -independent Mechanisms","volume":"280","author":"Kennell JA","year":"2005","unstructured":"Kennell JA, MacDougald OA. Wnt signaling inhibits adipogenesis through \u03b2-catenin-dependent and -independent Mechanisms. J Biol Chem. 2005;280(25):24004\u201324010.","journal-title":"J Biol Chem"},{"issue":"5481","key":"e_1_3_3_28_1","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.289.5481.950","article-title":"Inhibition of adipogenesis by Wnt signaling","volume":"289","author":"Ross SE","year":"2000","unstructured":"Ross SE, Hemati N, Longo KA, et al. Inhibition of adipogenesis by Wnt signaling. Science. 2000;289(5481):950\u2013953.","journal-title":"Science"},{"issue":"9","key":"e_1_3_3_29_1","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.3390\/cells10092330","article-title":"The candidate IBD risk gene CCNY is dispensable for intestinal epithelial homeostasis","volume":"10","author":"Molinas A","year":"2021","unstructured":"Molinas A, Heil S, Koch S. The candidate IBD risk gene CCNY is dispensable for intestinal epithelial homeostasis. Cells. 2021;10(9):2330.","journal-title":"Cells"},{"issue":"21","key":"e_1_3_3_30_1","doi-asserted-by":"crossref","first-page":"8239","DOI":"10.3390\/ijms21218239","article-title":"Cyclin Y is expressed in platelets and modulates integrin outside-in signaling","volume":"21","author":"Kyselova A","year":"2020","unstructured":"Kyselova A, Siragusa M, Anthes J, et al. Cyclin Y is expressed in platelets and modulates integrin outside-in signaling. Int J Mol Sci. 2020;21(21):8239.","journal-title":"Int J Mol Sci"},{"issue":"21","key":"e_1_3_3_31_1","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.1158\/1078-0432.CCR-07-5063","article-title":"Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with barrett\u2019s esophagus: a long-term prospective study","volume":"14","author":"Chao DL","year":"2008","unstructured":"Chao DL, Sanchez CA, Galipeau PC, et al. Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with barrett\u2019s esophagus: a long-term prospective study. Clin Cancer Res. 2008;14(21):6988\u20136995.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"e_1_3_3_32_1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/1947601913479022","article-title":"Cyclins and cell cycle control in cancer and disease","volume":"3","author":"Casimiro MC","year":"2012","unstructured":"Casimiro MC, Crosariol M, Loro E, et al. Cyclins and cell cycle control in cancer and disease. Genes & Cancer. 2012;3(11\u201312):649\u2013657.","journal-title":"Genes & Cancer"},{"issue":"4","key":"e_1_3_3_33_1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4161\/fly.4.4.12881","article-title":"Why cyclin Y? a highly conserved cyclin with essential functions","volume":"4","author":"Liu D","year":"2010","unstructured":"Liu D, Guest S, Finley RL. Why cyclin Y? a highly conserved cyclin with essential functions. Fly. 2010;4(4):278\u2013282.","journal-title":"Fly"},{"issue":"8","key":"e_1_3_3_34_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tcb.2010.05.002","article-title":"Emerging links between CDK cell cycle regulators and Wnt signaling","volume":"20","author":"Davidson G","year":"2010","unstructured":"Davidson G, Niehrs C. Emerging links between CDK cell cycle regulators and Wnt signaling. Trends Cell Biol. 2010;20(8):453\u2013460.","journal-title":"Trends Cell Biol"},{"issue":"8","key":"e_1_3_3_35_1","first-page":"359","article-title":"Lentivirus-mediated knockdown of cyclin Y (CCNY) inhibits glioma cell proliferation","volume":"18","author":"Xu Y","year":"2009","unstructured":"Xu Y, Wang Z, Wang J, et al. Lentivirus-mediated knockdown of cyclin Y (CCNY) inhibits glioma cell proliferation. Oncol Res Featuring Preclinical Clin Cancer Ther. 2009;18(8):359\u2013364.","journal-title":"Oncol Res Featuring Preclinical Clin Cancer Ther"},{"issue":"2","key":"e_1_3_3_36_1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s40471-019-00188-3","article-title":"The changing epidemiology of primary liver cancer","volume":"6","author":"Petrick JL","year":"2019","unstructured":"Petrick JL, McGlynn KA. The changing epidemiology of primary liver cancer. Curr Epidemiol Rep. 2019;6(2):104\u2013111.","journal-title":"Curr Epidemiol Rep"},{"issue":"2","key":"e_1_3_3_37_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2010.11.014","article-title":"Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges","volume":"305","author":"Bouchard MJ","year":"2011","unstructured":"Bouchard MJ, Navas-Martin S. Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett. 2011;305(2):123\u2013143.","journal-title":"Cancer Lett"},{"issue":"2","key":"e_1_3_3_38_1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4161\/cam.5.2.14403","article-title":"Dynamics of the Rho-family small GTPases in actin regulation and motility","volume":"5","author":"Spiering D","year":"2011","unstructured":"Spiering D, Hodgson L. Dynamics of the Rho-family small GTPases in actin regulation and motility. Cell Adhes Migr. 2011;5(2):170\u2013180.","journal-title":"Cell Adhes Migr"},{"issue":"4","key":"e_1_3_3_39_1","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.bbrc.2020.09.127","article-title":"Cyclin Y binds and activates CDK4 to promote the G1\/S phase transition in hepatocellular carcinoma cells via Rb signaling","volume":"533","author":"Chen L","year":"2020","unstructured":"Chen L, Wang X, Cheng H, et al. Cyclin Y binds and activates CDK4 to promote the G1\/S phase transition in hepatocellular carcinoma cells via Rb signaling. Biochem Biophys Res Commun. 2020;533(4):1162\u20131169.","journal-title":"Biochem Biophys Res Commun"},{"key":"e_1_3_3_40_1","first-page":"193","article-title":"Circulating plasma microRNAs as diagnostic markers for NSCLC","volume":"7","author":"Hou J","year":"2016","unstructured":"Hou J, Meng F, Chan LWC, et al. Circulating plasma microRNAs as diagnostic markers for NSCLC. Front Genet. 2016;7:193.","journal-title":"Front Genet"},{"key":"e_1_3_3_41_1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2147\/OTT.S180507","article-title":"Establishing a detection method for CCNY: a potentially significant clinical investigative marker in NSCLC patients","volume":"12","author":"Ma L","year":"2019","unstructured":"Ma L, Gu M, Teng Y, et al. Establishing a detection method for CCNY: a potentially significant clinical investigative marker in NSCLC patients. OTT. 2019;12:921\u2013932.","journal-title":"OTT"},{"key":"e_1_3_3_42_1","doi-asserted-by":"crossref","first-page":"684819","DOI":"10.3389\/fcell.2021.684819","article-title":"Cytoplasmic localization isoform of cyclin Y enhanced the metastatic ability of lung cancer via regulating tropomyosin 4","volume":"9","author":"Zhao X","year":"2021","unstructured":"Zhao X, Jiang M, Teng Y, et al. Cytoplasmic localization isoform of cyclin Y enhanced the metastatic ability of lung cancer via regulating tropomyosin 4. Front Cell Dev Biol. 2021;9:684819.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"e_1_3_3_43_1","doi-asserted-by":"crossref","first-page":"100773","DOI":"10.1016\/j.tranon.2020.100773","article-title":"Epithelial-mesenchymal transition in cancer: a historical overview","volume":"13","author":"Ribatti D","year":"2020","unstructured":"Ribatti D, Tamma R, Annese T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol. 2020;13(6):100773.","journal-title":"Transl Oncol"},{"issue":"3","key":"e_1_3_3_44_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.devcel.2019.04.026","article-title":"EMT and cancer: more than meets the eye","volume":"49","author":"Derynck R","year":"2019","unstructured":"Derynck R, Weinberg RA. EMT and cancer: more than meets the eye. Dev cell. 2019;49(3):313\u2013316.","journal-title":"Dev cell"},{"issue":"6","key":"e_1_3_3_45_1","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI36183","article-title":"Biomarkers for epithelial-mesenchymal transitions","volume":"119","author":"Zeisberg M","year":"2009","unstructured":"Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119(6):1429\u20131437.","journal-title":"J Clin Invest"},{"issue":"7","key":"e_1_3_3_46_1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1158\/2159-8290.CD-19-1446","article-title":"Targeting MET dysregulation in cancer","volume":"10","author":"Recondo G","year":"2020","unstructured":"Recondo G, Che J, J\u00e4nne PA, et al. Targeting MET dysregulation in cancer. Cancer Discov. 2020;10(7):922\u2013934.","journal-title":"Cancer Discov"},{"issue":"8","key":"e_1_3_3_47_1","doi-asserted-by":"crossref","first-page":"10161","DOI":"10.1007\/s13277-016-4818-3","article-title":"Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway","volume":"37","author":"Liu H","year":"2016","unstructured":"Liu H, Shi H, Fan Q, et al. Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway. Tumour Biol. 2016;37(8):10161\u201310175.","journal-title":"Tumour Biol"},{"key":"e_1_3_3_48_1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"11","author":"Momenimovahed Z","year":"2019","unstructured":"Momenimovahed Z, Tiznobaik A, Taheri S, et al. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019;11:287\u2013299.","journal-title":"Int J Womens Health"},{"issue":"5","key":"e_1_3_3_49_1","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.3892\/or.2016.5126","article-title":"RNAi-mediated downregulation of cyclin Y to attenuate human breast cancer cell growth","volume":"36","author":"Yan F","year":"2016","unstructured":"Yan F, Wang X, Zhu M, et al. RNAi-mediated downregulation of cyclin Y to attenuate human breast cancer cell growth. Oncol Rep. 2016;36(5):2793\u20132799.","journal-title":"Oncol Rep"},{"issue":"1","key":"e_1_3_3_50_1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13046-022-02362-w","article-title":"CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1","volume":"41","author":"Li X","year":"2022","unstructured":"Li X, Li J, Xu L, et al. CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1. J Exp Clin Cancer Res. 2022;41(1):149.","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"e_1_3_3_51_1","doi-asserted-by":"crossref","first-page":"111331","DOI":"10.1016\/j.celrep.2022.111331","article-title":"CDK14 inhibition reduces mammary stem cell activity and suppresses triple negative breast cancer progression","volume":"40","author":"Zhang M","year":"2022","unstructured":"Zhang M, Zhang L, Geng A, et al. CDK14 inhibition reduces mammary stem cell activity and suppresses triple negative breast cancer progression. Cell Rep. 2022;40(11):111331.","journal-title":"Cell Rep"}],"container-title":["Cell Cycle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15384101.2022.2162668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T13:49:58Z","timestamp":1695390598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15384101.2022.2162668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,4,18]]}},"alternative-id":["10.1080\/15384101.2022.2162668"],"URL":"https:\/\/doi.org\/10.1080\/15384101.2022.2162668","relation":{},"ISSN":["1538-4101","1551-4005"],"issn-type":[{"value":"1538-4101","type":"print"},{"value":"1551-4005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kccy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kccy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-08-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}